We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
5 similar Capital on Demand Sales Agreement contracts by aTYR PHARMA INC, Tracon Pharmaceuticals, Inc., MEI Pharma, Inc.
MEI PHARMA, INC. Common Stock ($0.00000002 par value per share) Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • February 21st, 2024 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
Standard Contracts
Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • March 15th, 2022 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • New York
Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • March 24th, 2021 • aTYR PHARMA INC • Biological products, (no disgnostic substances) • New York
Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • December 9th, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • September 7th, 2018 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York